Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Bulk Drug Intermediates >  (7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol

(7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol

Basic information Safety Supplier Related

(7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol Basic information

Product Name:
(7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol
Synonyms:
  • Estra-1,3,5(10)-triene-3,17-diol, 7-(9-broMononyl)-, (7a,17b)- (9CI)
  • Fulvestrant Intermediates--5-1(N-3-1)
  • Estra-1,3,5(10)-triene-3,17-diol, 7-(9-bromononyl)-, (7α,17β)-
  • (7A,17BETA)-7-(9-BROMONONYL)ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
  • (7α,17β)-7-(9-bromononyl)estra-1,3,5(10)-triene-3,17-diol
  • (7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol
  • Fulvestrant interMediate N-2(1)
  • (7R,8R,9S,13S,14S,17S)-7-(9-bromononyl)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
CAS:
875573-67-4
MF:
C27H41BrO2
MW:
477.53
EINECS:
682-386-6
Mol File:
875573-67-4.mol
More
Less

(7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol Chemical Properties

Boiling point:
586.1±50.0 °C(Predicted)
Density 
1.196
storage temp. 
Sealed in dry,Room Temperature
pka
10.27±0.70(Predicted)
InChIKey
ILWDBZWOZQESSY-RIVKPNGLNA-N
SMILES
C([C@@H]1CC2=CC(O)=CC=C2[C@@]2([H])CC[C@@]3([C@@H](O)CC[C@@]3([H])[C@]12[H])C)CCCCCCCCBr |&1:1,10,14,15,19,21,r|
More
Less

(7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol Usage And Synthesis

Uses

(7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol is used in the synthetic preparation of 7α-alkylated 19-norsteroids.

Definition

(7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol is a Fulvestrant intermediate.

Synthesis

875573-66-3

875573-67-4

Synthesis of (7R,8R,9S,13S,14S,17S)-7-(9-bromononyl)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a ]phenanthrene-3,17-diol was performed in the following general steps: the compound of Formula II (5.0 g) prepared in Example 1 was added to a reaction flask with methanol (50 mL) and heated until dissolved. Subsequently, aqueous hydrobromic acid (5 mL of 40 mL) was slowly added and the reaction was carried out at 60 °C for 2 hours. After completion of the reaction, it was cooled to room temperature and the solid product was collected by filtration. The resulting solid was dried in a vacuum oven at 40 °C for 8 h to afford the compound of formula III (4.3 g), which was tested to be 97.7% pure.

References

[1] Patent: US2006/30552, 2006, A1. Location in patent: Page/Page column 25
[2] Patent: CN107325143, 2017, A. Location in patent: Paragraph 0010; 0011; 0012

(7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diolSupplier

Hangzhou nuotong biotechnology co. LTD Gold
Tel
0571-86297909 15268405618
Email
sisi.xiang@sinopep.com
Hunan Eurasian Pharmaceutical Co. Ltd. Gold
Tel
0592-5789919 13328776692
Email
2851802018@qq.com;2851802016@qq.com
Beijing HwrkChemical Technology Co., Ltd
Tel
010-89508211 18501085097
Email
sales.bj@hwrkchemical.com
BeiJing Hwrk Chemicals Limted
Tel
0757-86329057 18934348241
Email
sales4.gd@hwrkchemical.com
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Email
info@chemexpress.com